NO20020760D0 - Farmasöytiske sammensetninger for oral og topisk administrasjon - Google Patents

Farmasöytiske sammensetninger for oral og topisk administrasjon

Info

Publication number
NO20020760D0
NO20020760D0 NO20020760A NO20020760A NO20020760D0 NO 20020760 D0 NO20020760 D0 NO 20020760D0 NO 20020760 A NO20020760 A NO 20020760A NO 20020760 A NO20020760 A NO 20020760A NO 20020760 D0 NO20020760 D0 NO 20020760D0
Authority
NO
Norway
Prior art keywords
oral
pharmaceutical compositions
topical administration
topical
administration
Prior art date
Application number
NO20020760A
Other languages
English (en)
Other versions
NO20020760L (no
Inventor
Tomas Andrysek
Milan Stuchlik
Ales Vrana
Alexandr Jegorov
Josef Stuchlik
Vladimir Matha
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020760(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galena As filed Critical Galena As
Publication of NO20020760D0 publication Critical patent/NO20020760D0/no
Publication of NO20020760L publication Critical patent/NO20020760L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
NO20020760A 1999-08-17 2002-02-15 Farmasöytiske sammensetninger for oral og topisk administrasjon NO20020760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
NO20020760D0 true NO20020760D0 (no) 2002-02-15
NO20020760L NO20020760L (no) 2002-04-16

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020760A NO20020760L (no) 1999-08-17 2002-02-15 Farmasöytiske sammensetninger for oral og topisk administrasjon
NO20034778A NO20034778D0 (no) 1999-08-17 2003-10-24 Farmasöytiske sammensetninger for oral og topisk anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20034778A NO20034778D0 (no) 1999-08-17 2003-10-24 Farmasöytiske sammensetninger for oral og topisk anvendelse

Country Status (40)

Country Link
US (1) US20070190132A1 (no)
EP (2) EP1334717B1 (no)
JP (2) JP2003507343A (no)
KR (2) KR100828748B1 (no)
CN (2) CN101406453A (no)
AR (2) AR025324A1 (no)
AT (2) ATE288766T1 (no)
AU (1) AU777740B2 (no)
BR (1) BR0013385A (no)
CA (2) CA2380951C (no)
CO (1) CO5380014A1 (no)
CY (1) CY1105318T1 (no)
CZ (2) CZ296170B6 (no)
DE (2) DE60018081T2 (no)
DK (2) DK1334717T3 (no)
EE (2) EE04955B1 (no)
EG (1) EG23994A (no)
ES (2) ES2311077T3 (no)
GB (1) GB2355656B (no)
HK (1) HK1049629A1 (no)
HR (1) HRP20020154B1 (no)
HU (1) HUP0203236A3 (no)
IL (4) IL148200A0 (no)
JO (1) JO2324B1 (no)
MX (1) MXPA02001631A (no)
NO (2) NO20020760L (no)
NZ (1) NZ517271A (no)
PE (1) PE20010636A1 (no)
PL (1) PL192769B1 (no)
PT (2) PT1210119E (no)
RU (2) RU2279894C2 (no)
SA (1) SA00210487B1 (no)
SG (1) SG143019A1 (no)
SI (1) SI1210119T1 (no)
SK (2) SK2482002A3 (no)
TN (1) TNSN00173A1 (no)
UA (2) UA72539C2 (no)
UY (1) UY26303A1 (no)
WO (1) WO2001012229A1 (no)
ZA (2) ZA200308221B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
KR101061679B1 (ko) * 2002-12-04 2011-09-02 닛신 파마 가부시키가이샤 코엔자임 ｑ10 을 함유하는 수용성 조성물
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
EP1855659A2 (en) * 2005-02-24 2007-11-21 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
EP2364140A1 (en) * 2008-11-28 2011-09-14 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
BRPI1008983A2 (pt) * 2009-03-12 2016-03-22 Advance Holdings Ltd formulação farmacêutica
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
US9867769B2 (en) 2015-03-27 2018-01-16 Arch Personal Care Products, Lp Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
CA2283780A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
ES2219895T3 (es) * 1997-07-29 2004-12-01 PHARMACIA & UPJOHN COMPANY Formulacion autoemulsionante para compuestos lipofilos.
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
PL192769B1 (pl) 2006-12-29
PT1210119E (pt) 2005-05-31
IL158108A0 (en) 2004-03-28
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
AR043106A2 (es) 2005-07-20
CY1105318T1 (el) 2010-03-03
US20070190132A1 (en) 2007-08-16
HRP20020154B1 (en) 2006-07-31
EP1334717B1 (en) 2008-07-30
DK1210119T3 (da) 2005-06-20
UA75926C2 (en) 2006-06-15
HUP0203236A3 (en) 2004-06-28
HK1049629A1 (zh) 2003-05-23
CN101406453A (zh) 2009-04-15
EE200200075A (et) 2003-04-15
EG23994A (en) 2008-03-10
CZ296591B6 (cs) 2006-04-12
ATE402691T1 (de) 2008-08-15
NO20034778D0 (no) 2003-10-24
CN1382061A (zh) 2002-11-27
ES2311077T3 (es) 2009-02-01
MXPA02001631A (es) 2003-07-14
BR0013385A (pt) 2002-05-07
CA2452118A1 (en) 2001-02-22
DE60018081D1 (de) 2005-03-17
NZ517271A (en) 2004-02-27
DE60322454D1 (de) 2008-09-11
UY26303A1 (es) 2001-03-16
SA00210487B1 (ar) 2006-09-10
TNSN00173A1 (en) 2005-11-10
JP2003507343A (ja) 2003-02-25
NO20020760L (no) 2002-04-16
WO2001012229A1 (en) 2001-02-22
GB9919288D0 (en) 1999-10-20
ZA200201315B (en) 2004-06-30
EE04954B1 (et) 2008-02-15
HRP20020154A2 (en) 2003-12-31
CA2380951A1 (en) 2001-02-22
DE60018081T2 (de) 2006-01-05
GB2355656A (en) 2001-05-02
JO2324B1 (en) 2005-09-12
IL148200A0 (en) 2002-09-12
PT1334717E (pt) 2008-10-09
RU2003133451A (ru) 2005-04-20
AU6461300A (en) 2001-03-13
SI1210119T1 (en) 2005-06-30
CA2380951C (en) 2010-03-23
EP1210119B1 (en) 2005-02-09
PE20010636A1 (es) 2001-06-02
KR100828748B1 (ko) 2008-05-09
IL158108A (en) 2010-04-15
SK2482002A3 (en) 2002-12-03
KR20050095651A (ko) 2005-09-29
UA72539C2 (en) 2005-03-15
EP1334717A2 (en) 2003-08-13
PL353445A1 (en) 2003-11-17
RU2279894C2 (ru) 2006-07-20
IL148200A (en) 2007-12-03
ZA200308221B (en) 2004-09-29
AU777740B2 (en) 2004-10-28
KR20020059367A (ko) 2002-07-12
GB2355656B (en) 2004-04-07
SG143019A1 (en) 2008-06-27
EE200300371A (et) 2003-10-15
EP1210119A1 (en) 2002-06-05
ES2237443T3 (es) 2005-08-01
DK1334717T3 (da) 2008-11-24
EP1334717A3 (en) 2004-01-02
CZ2002575A3 (cs) 2003-05-14
CZ296170B6 (cs) 2006-01-11
AR025324A1 (es) 2002-11-20
HUP0203236A2 (hu) 2003-01-28
RU2279895C2 (ru) 2006-07-20
ATE288766T1 (de) 2005-02-15
SK286083B6 (sk) 2008-03-05
CO5380014A1 (es) 2004-03-31
EE04955B1 (et) 2008-02-15
JP2004238399A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
NO20020760D0 (no) Farmasöytiske sammensetninger for oral og topisk administrasjon
NO20020208L (no) Flytende sammensetninger for oral administrasjon
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
NO20015175D0 (no) Farmasöytisk sammensetning
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
FR2802423B1 (fr) Compositions pharmaceutiques
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
FI4488U1 (fi) Farmaseuttinen koostumus
EE200100281A (et) Analgeetiline ravimkoostis
GB9902227D0 (en) Pharmaceutical composition for topical administration
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
EP1188440A4 (en) MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
SE9904414D0 (sv) Pharmaceutical composition and use
DK1272499T3 (da) Farmaceutiske præparater indeholdende oligosaccharider og fremstilling heraf
FI964663A0 (fi) Farmaceutisk analgetisk komposition foer lokal administrering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application